Publications
Should Ipilimumab Be the New “Standard” for Refractory MCC?
In this editorial, we discuss the role of ipilimumab in anti-PD-1 refractory Merkel cell carcinoma. This topic was presented at the Third International Symposium for MCC in Houston, Texas on May 4th 2024.
A Closer Look: Evaluating Mohs Surgery’s Role in the Treatment of Invasive Melanoma of the Head and Neck
In this Perspectives on the Science piece, we reflect on the implications of the recently conducted multicenter study on the treatment of invasive head and neck melanoma using Mohs micrographic surgery.
Surgical Factors Affecting Regionally Metastatic Cutaneous Squamous Cell Carcinoma to the Parotid Gland
Understanding the impact of surgical treatment on regionally metastatic cutaneous squamous cell carcinoma (cSCC) is important as treatment paradigms shift with the introduction of immune checkpoint inhibitors. Herein, we aim to describe surgical impact on outcomes for regionally metastatic cSCC
Lacking Overall IMspiration for Triplet Therapy in Melanoma? A Review of the Interim Analysis of IMspire150.
In this Perspectives on the Science piece, we reflect on the impact of the recently published article by Ascierto et al. in Lancet Oncology that provides interim results from IMspire150.
Tumor-Infiltrating Lymphocyte Therapy for Advanced Melanoma: Ready for Prime Time?
In this Perspectives on the Science piece, published in the Journal of Cutaneous Oncology, we reflect on the impact of the recently published article “Tumor-Infiltrating Lymphocyte Therapy or Ipilimumab in Advanced Melanoma”.
StoryboardR - An R Package and Shiny Application Designed to Visualize Real-World Data From Clinical Patient Registries
We created StoryboardR, an R package and Shiny application facilitates the data visualization of real-world data from tumor registries captured in REDCap®.
Ipi/Nivo for Advanced MCC
In this Perspectives on the Science piece, published in the Journal of Cutaneous Oncology, we reflect on the impact of the recently published article “Combined Nivolumab and Ipilimumab with or without Stereotactic Body Radiation Therapy for Advanced Merkel cell carcinoma - A Randomised, Open Label, Phase 2 Trial”.
Neoadjuvant ICI for Resectable CSCC
In this Perspectives on the Science piece, published in the Journal of Cutaneous Oncology we reflect on the impact of the recently published article Neoadjuvant Cemiplimab for Stage II to IV Cutaneous Squamous-Cell Carcinoma.
Generalizable EHR-R-REDCap Pipeline for a National Multi-Institutional Rare Tumor Patient Registry
We present a clinical informatics pipeline designed to capture large-scale structured laboratory EHR data.
BodyMapR - An R Package and Shiny Application Designed to Generate Anatomical Visualizations of Cancer Lesions
R package for enhanced visualizations of cancer lesions
Impact of an Evolving Regulatory Landscape on Skin Cancer Drug Development in the U.S
We present an analysis of the impact of an evolving regulatory landscape on skin cancer drug development.
GENETEX - A GENomics Report TEXt Mining R Package and Shiny Application Designed to Capture Real-World Clinico-Genomic Data
We created GENETEX, an R package and Shiny application for text mining genomic reports from EHR and direct import into REDCap®.
Immunotherapy for Non-Melanoma Skin Cancer
We review the latest trends in cancer care for Non-Melanoma skin cancer.
Commentary on Surgical Margins in MCC
A REDCap-Based Operational Tool to Guide Care Coordination in a Multidisciplinary Cutaneous Oncology Clinic
Clinical spectrum of cutaneous melanoma morphology.
OBJECTIVE: To classify nonacral cutaneous melanomas into distinct morphologic clusters and characterize clusters’…